Demand for Smart Inhalers Gains Pace to Curb Respiratory Disorders

San Francisco, California, May 02, 2017: TMR Research announces a new report on the global smart inhalers market. The report is based on a solid database of the historical trajectory and deviations exhibited by the global smart inhalers market. The present figures of the market are presented in the report in great detail. Based on a solid analysis of the patterns exhibited by the market, reliable projections are made regarding the future trajectory of the global smart inhalers market. The report is titled ‘Smart Inhalers Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025.’

The global smart inhalers market is a key part of the digitalization movement in the healthcare sector. Smart inhalers are digital respiratory aids that record various aspects of their usage, including the patient’s adherence to the prescribed dosage and the amount being delivered each time. The utilization of modern smart electronics has resulted in smart inhalers that don’t present any inconvenience to the user and can also upload the tracked information to personal electronic devices. Due to the steady incorporation of digital accessories in the healthcare sector, the global smart inhalers market is likely to exhibit steady growth in the coming years.

The rising prevalence of asthma and COPD (chronic obstructive pulmonary disease) has been a prime driver for the global smart inhalers market and is likely to be influential in their rising demand in the coming years. Mounting pollution levels and the increasing adherence to an unhealthy, inactive lifestyle has resulted in a steady rise in the incidence of respiratory conditions, particularly in urban centers. This is likely to drive the demand for smart inhalers due to the rising disposable income of individual consumers. Though the high costs of smart inhalers could restrict their demand in developing regions, developed regions are likely to sustain the demand from the global smart inhalers market in the coming years.

North America is likely to remain the dominant regional market for smart inhalers in the coming years. Allied to its conventional status as the pioneer and early adopter of technological advancements, the strong support from government-supported healthcare agencies has also helped the smart inhalers market in North America.

The increasing demand for home-based care and remote healthcare monitoring is also likely to be a key factor in the growth of the global smart inhalers market in the coming years. As many respiratory conditions don’t require regular physical consultations, doctors as well as patients are turning to digital communication tools to set up remote monitoring facilities. The global smart inhalers market is likely to be a crucial part of this change due to the ease of communicating their recorded data to physicians.

The report also presents a comprehensive analysis of the competitive landscape of the global smart inhalers market. Key smart inhalers market players such as AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Cohero Health LLC, Novartis AG, Boehringer Ingelheim GmbH, and GlaxoSmithKline plc are profiled in the report.

McDonald’s Introduces Frork as New Way of Savoring Sandwiches, Burgers

McDonald’s Corp. has been looking to cash in on its years of customization effort on the part of a new line of chicken sandwiches and burgers called Signature Crafted Recipes with the introduction of “frork”. McDonald’s latest spoof infomercial, which stars Anthony Sullivan, a popular pitchman, has entertainingly explained how the fork-shaped, silicone utensil will enhance the eating experience of customers opting for the customized Signature Crafted Recipes line of fast food. McDonald’s “supremely superfluous” fry-fork that has fries for prongs could solve the only one problem of “topping dropping” while having the Signature Crafted sandwiches, as stated by Sullivan in the infomercial.

Promotional Giveaways, Including Frork, Hype Signature Crafted Recipes

Signature Crafted Recipes such as Pico Guacamole, Sweet BBQ Bacon, and Maple Bacon Dijon have been anticipated to be among the handpicked offerings of McDonald’s. The Signature Crafted sandwiches have been prophesied to bear price tags which read an average US$4.99 to US$5.19. The infomercial has suggested that the promotional product frork could make the eating experience even more ecstatic by helping customers to slop up Signature Crafted sandwich toppings if they happen to fall out.

1-844-MCD-FRORK is the toll free number provided by McDonald’s to facilitate information on how to receive coupons for Signature Crafted sandwiches and the frork. On May 5, the fast food giant has been predicted to plan for a frork giveaway at worldwide locations on the purchase of a Signature Crafted sandwich. From May 4 to May 8, McDonald’s could give away a free drink and medium fries on a similar purchase.

In the past, McDonald’s had adopted a related strategy to promote Shamrock Shake’s newer versions by giving away engineered straws and Big Mac Special Sauce bottles for exciting sizes of Big Macs.

Amazon Announces Shutdown of ‘Underground Actually Free’ Program

Amazon is shutting down support for the free app service on its online store. The e-commerce giant is discontinuing “Underground Actually Free” – the program debuted in 2015 as a means to deliver Android apps to users at no cost. The program was pitched as a means for app developers to showcase their software to consumers via Amazon’s online app store at no cost.

The arrangement presented a win-win scenario for the online retailer as well as the app developer. Developers participating in the program could showcase their apps via Amazon’s app store and in return, Amazon would pay royalties to developers based on the time people spent on free apps. Some of the popular offerings of the program include “Goat Simulator”, “Star Wars Rebels: Recon Missions”, and “Office Suite Pro 8.”

App Developers Need to Satisfy Conditions to Qualify for Amazon’s Underground App Store

To qualify for the program, developers needed to have a mobile app available on Google’s Play store or Apple’s app store for purchase, and the apps needed to work on at least one non-Amazon mobile device.

The free app service was launched to reward developers for developing compelling apps and at the same time convince users to download apps from Amazon’s app store. Amazon hoped that users would be lured to its app store as some apps would be available for free that are otherwise available to buy through rivals like Apple or Google.

Current customers of Fire Tablet can continue to use previously installed Underground Apps and will have continued access to Underground Actually Free store. However, access to the Underground store will be restricted to currently supported New Fire tablet devices and not new devices. Amazon will stop accepting submissions for new apps and games on May 31.

EMBL Collaborates with Enamine for Research on Cancer Treatment

The European Molecular Biology Laboratory (EMBL) and Enamine, have collaborated to develop novel small molecules which works against anti-cancer targets. As per the terms of this collaboration, Enamine is providing medicinal chemistry, library synthesis, and biological services to EMBL for their cause and together they expect to focus on creating new cancer therapeutics and novel modes of action. The collaboration comprises the deployment of medicinal chemists who are Full Time Equivalent (FTE), at Enamine.

 Millions of Compounds Needed to Up Chemical Diversity at Screening Decks

For many years, the EMBL has been working with Enamine to improve the chemical space of their screening library, stated the Head of Chemical Biology Core Facility at EMBL, Joe Lewis. With the realization that above 2 mn collection of compounds can provide quality compounds, there is a need for increasing the chemical diversity of their screening deck. Thus, Enamine was chosen to outsource for their medicinal chemistry discovery program, as the company can help in the field of drug development and chemical biology.

Integration of Chemistry and Biology Service Portfolio

As per David Will, the Head of Medicinal Chemistry at EMBL, the collaboration with Enamine will help their project’s goal of identifying the targets from phenotypic screens, and then synthesizing and triaging patentable preclinical compounds that are new. The access to the world’s largest collection of building blocks at Enamine will go a long way in developing a preclinical compound. The integration of chemistry and biology service portfolio is apt for this kind of research.

“Our collaboration with EMBL illustrates our established engagement with non-profit academic research institutions and disease foundations in their search for strong and committed partners in the most challenging discovery research projects. We look forward to our continued successful work with EMBL”, concluded Michael Bossert, Head Strategic Alliances at Enamine.